A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis

Carcinogenesis

Volumn 33, Issue 2, 2012, Pages 312-319

  Zhang, Jing ^a   Sarkar, Susobhan ^a   Cua, Rowena ^a   Zhou, Yan ^b   Hader, Walter ^a   Wee Yong, V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLAGEN GEL; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 6;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MICROGLIA; PRIORITY JOURNAL; PROTEIN INTERACTION; TUMOR PROMOTION;

EID: 84863049147     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr289     Document Type: Article

References (56)

1. Huse, J.T. et al. (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer, 10, 319-331.
2. Charles, N.A. et al. (2011) The brain tumor microenvironment. Glia, 59, 1169-1180.
3. Proudfoot, A.E. (2002) Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol., 2, 106-115.
4. Teicher, B.A. et al. (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res., 16, 2927-2931.
5. Oh, J.W. et al. (1999) Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J. Neurovirol., 5, 82-94.
6. Kielian, T. et al. (2002) MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J. Neurooncol., 56, 1-12.
7. Desbaillets, I. et al. (1997) Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med., 186, 1201-1212.
8. Salmaggi, A. et al. (2004) CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J. Neurooncol., 67, 305-317.
9. Bajetto, A. et al. (2006) Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem. Int., 49, 423-432.
10. Terasaki, M. et al. (2011) CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol., 28, 89-97.
11. Belperio, J.A. et al. (2000) CXC chemokines in angiogenesis. J. Leukoc. Biol., 68, 1-8.
12. Zhou, Y. et al. (2005) The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells. Carcinogenesis, 26, 2058-2068.
13. Sciume, G. et al. (2010) Chemokines and glioma: invasion and more. J. Neuroimmunol., 224, 8-12.
14. Zhou, Y. et al. (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem., 277, 49481-49487.
15. Zhang, J. et al. (2005) The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis, 26, 2069-2077.
16. Hussain, S.F. et al. (2006) The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncol., 8, 261-279.
17. von Hanwehr et al. (1984) Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J. Neurosurg., 60, 1138-1147.
18. Ben-Neriah, Y. et al. (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol., 12, 715-723.
19. Le, D.M. et al. (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J. Neurosci., 23, 4034-4043.
20. Sarkar, S. et al. (2006) Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res., 66, 11771-11780.
21. Chabot, S. et al. (2000) Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS. Neurology, 55, 1497-1505.
22. Brat, D.J. et al. (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncol., 7, 122-133.
23. Sun, S. et al. (2011) Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB. J. Neurooncol., 101, 1-14.
24. de la Iglesia, N. et al. (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J. Neurosci., 28, 5870-5878.
25. Yamayoshi, T. et al. (2004) Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J. Pathol., 204, 110-118.
26. Niu, J. et al. (2007) Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors. J. Biol. Chem., 282, 6001-6011.
27. Finch, P.W. et al. (2006) Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J. Natl Cancer Inst., 98, 812-824.
28. Zang, X.P. et al. (2006) Enhanced motility of KGF-transfected breast cancer cells. Anticancer Res., 26, 961-966.
29. Fulci, G. et al. (2007) Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res., 67, 9398-9406.
30. Balkwill, F. et al. (2001) Inflammation and cancer: back to Virchow?. Lancet, 357, 539-545.
31. Ping, Y.F. et al. (2011) The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J. Pathol., 224, 344-354.
32. Calatozzolo, C. et al. (2011) Expression of the new CXCL12 receptor, CXCR7, in gliomas. Cancer Biol. Ther., 11, 242-253.
33. Rolhion, C. et al. (2001) Interleukin-6 overexpression as a marker of malignancy in human gliomas. J. Neurosurg., 94, 97-101.
34. Tchirkov, A. et al. (2001) IL-6 gene amplification and expression in human glioblastomas. Br. J. Cancer, 85, 518-522.
35. Iwami, K. et al. (2011) Cytokine networks in glioma. Neurosurg. Rev., 34, 253-264.
36. Li, R. et al. (2010) IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol. Rep., 23, 1553-1559.
37. Wang, H. et al. (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells, 27, 2393-2404.
38. Li, R. et al. (2010) IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol. Rep., 23, 1553-1559.
39. Graeber, M.B. et al. (2002) Microglia in brain tumors. Glia, 40, 252-259.
40. Hwang, S.Y. et al. (2009) Induction of glioma apoptosis by microgliasecreted molecules: the role of nitric oxide and cathepsin B. Biochim. Biophys. Acta, 1793, 1656-1668.
41. Mora, R. et al. (2009) TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia, 57, 561-581.
42. Rosales, A.A. et al. (1997) Microglia-derived cytotoxic factors. Part I: inhibition of tumor cell growth in vitro. Brain Res., 748, 195-204.
43. Brantley, E.C. et al. (2010) Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl. Oncol., 3, 380-388.
44. Zhang, L. et al. (2009) Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia, 57, 1458-1467.
45. Galarneau, H. et al. (2007) Increased glioma growth in mice depleted of macrophages. Cancer Res., 67, 8874-8881.
46. Yang, I. et al. (2010) The role of microglia in central nervous system immunity and glioma immunology. J. Clin. Neurosci., 17, 6-10.
47. Wu, A. et al. (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-oncol., 12, 1113-1125.
48. Platten, M. et al. (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol., 54, 388-392.
49. Kerber, M. et al. (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res., 68, 7342-7351.
50. Markovic, D.S. et al. (2009) Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc. Natl Acad. Sci. USA, 106, 12530-12535.
51. Zhai, H. et al. (2011) Microglia/macrophages promote glioma progression. Glia, 59, 472-485.
52. Bettinger, I. et al. (2002) Microglia promote glioma migration. Acta Neuropathol., 103, 351-355.
53. Sliwa, M. et al. (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain, 130, 476-489.
54. Markovic, D.S. et al. (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol., 64, 754-762.
55. Nuttall, R.K. et al. (2007) Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia, 55, 516-526.
56. Markovic, D.S. et al. (2011) Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav. Immun., 25, 624-628.